Felix Health vs Hers Canada (2026): GLP-1 Weight Loss Comparison for Women

At a Glance

What Is Hers Canada?

Hers is the women-focused brand from the Hims parent company (Hims & Hers Health, Inc.), a US-listed consumer health company. Where Hims targets men with hair loss, sexual health, and skincare products alongside GLP-1, Hers is designed specifically for women - with offerings spanning weight management, mental health, skincare, sexual health, and hormonal health.

In Canada, Hers operates as a telehealth platform connecting women with licensed Canadian physicians for prescription services in multiple health categories. GLP-1 weight management prescriptions are available as one of those categories. The platform is particularly strong in its women-focused user experience - intake forms, clinical language, and content are all built with women's health considerations and communication preferences in mind.

Hers holds LegitScript certification for its Canadian pharmacy operations and uses licensed Canadian physicians for all clinical assessments. Like Hims, it entered Canada as a US company adapting its model to the Canadian regulatory environment rather than as a company built natively in Canada.

GLP-1 for Women: What Matters

GLP-1 medications are prescribed to both men and women, and the clinical eligibility criteria - BMI thresholds and comorbidity requirements - are the same regardless of sex. However, there are several clinically relevant factors that affect women on GLP-1 therapy specifically.

Hormonal considerations: GLP-1 medications interact with hormonal systems. Women who are taking oral contraceptives should be aware that GLP-1 medications - by slowing gastric emptying - can potentially reduce the absorption and efficacy of oral birth control pills. This is an important counselling point that should be raised at intake and during follow-up. A platform with strong women's health clinical infrastructure is better positioned to address this proactively.

Menstrual cycle effects: Some women on GLP-1 therapy report changes to menstrual cycle regularity, particularly during early titration. This is not widely documented in clinical trials but is reported in patient communities and emerging clinical literature. A women-focused platform is more likely to include this in its patient education and follow-up monitoring.

Pregnancy: GLP-1 medications are not approved for use during pregnancy and should be discontinued before attempting conception. Women of reproductive age on GLP-1 therapy need clear clinical guidance on this. Both Felix and Hers would be expected to address this in clinical intake, but Hers' women-focused clinical protocols are more explicitly designed around reproductive health considerations.

Mental health comorbidities: Women seeking weight management services have higher rates of co-occurring eating disorders and body image concerns compared to the general population. Hers' inclusion of mental health services within the platform means women who need concurrent support can access it without needing a separate provider.

Clinical Approach

Felix Health's clinical approach is gender-neutral. The intake process, clinical protocols, and follow-up cadence are the same for male and female patients. This is not a criticism - GLP-1 eligibility and dosing are the same regardless of sex, and Felix's clinical quality is high. But the clinical documentation, language, and educational content are not specifically designed around women's experiences of weight management.

Hers' clinical approach is women-centered from the start. Intake questions address menstrual cycle history, contraception, pregnancy status, and women-specific comorbidities as standard components of the clinical assessment - not as optional supplementary fields. The clinical team is oriented toward women's health broadly, not only toward GLP-1 prescribing specifically. This means the clinical context for your GLP-1 prescription includes consideration of how it interacts with your other health needs as a woman.

For GLP-1 prescribing and dose management specifically, both platforms use licensed Canadian physicians following the same Health Canada eligibility criteria and standard titration protocols. The clinical quality at the prescribing level is comparable. The difference is in the breadth of clinical context and the women-specific screening and education built into the Hers platform.

Pricing

Felix Health publishes its pricing before intake: $99 one-time consultation and approximately $149 per month all-in for generic semaglutide, with clinical support and delivery included. This transparency is one of Felix's clearest practical advantages.

Hers Canada, like Hims, does not publish its GLP-1 pricing before intake. Pricing is disclosed after completing the intake questionnaire. Third-party reporting suggests pricing is broadly competitive with Felix - in the $140-160 range for generic semaglutide - but patients cannot confirm this without going through the intake process.

For patients considering multiple platforms before committing, the pricing opacity of Hers creates a research friction that Felix does not. If you want to compare costs before starting an intake, Felix gives you the numbers; Hers requires you to complete intake first.

For patients who are already committed to a women-focused platform and are choosing between Hers and Maple (the other major Canadian women-accessible generalist telehealth), Hers' pricing model may be more competitive than Maple's per-consult structure for long-term GLP-1 use.

Province Coverage

Felix Health and Hers Canada have identical province coverage gaps: neither serves Quebec or New Brunswick. Both platforms cover Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, Nova Scotia, PEI, and Newfoundland and Labrador.

For women in Quebec or New Brunswick who want an online GLP-1 program, neither Felix nor Hers is an option. Maple and MyRocky both serve Quebec; MyRocky serves New Brunswick. If province coverage is the deciding factor, the choice between Felix and Hers becomes irrelevant.

Product Range Beyond GLP-1

Felix Health offers one product category: GLP-1 weight management. Its entire platform - clinical protocols, educational content, follow-up cadence, and customer support - is built around semaglutide and tirzepatide therapy. If your health goal is weight management using GLP-1 medications, this specialization is a significant advantage.

Hers Canada extends well beyond GLP-1. The platform covers mental health (anxiety, depression - therapy and medication), skincare (prescription topicals for acne, hyperpigmentation), sexual health and libido, and hormonal health. For women who want a single telehealth platform managing multiple health needs, Hers offers a cohesive experience across those categories in a way that Felix cannot.

The practical question is whether you want GLP-1 specialization or platform breadth. A woman who is primarily focused on GLP-1 weight loss and has no other telehealth needs benefits from Felix's clinical depth in that category. A woman managing GLP-1 alongside anxiety medication and a skincare prescription may find Hers' multi-category platform a meaningful convenience improvement.

Patient Experience

Felix Health's user experience is functional and purpose-built for GLP-1 patients. Intake is streamlined around GLP-1 eligibility criteria. Patient communications and educational content are weight-management focused. The interface is clean and optimized for the specific journey from assessment to prescription to ongoing management.

Hers has invested more heavily in the user experience design and brand presentation specifically for women. The visual language, communication style, and content library reflect a deliberate effort to create a platform that women find approachable and resonant. This is not purely cosmetic - the experience of interacting with a healthcare platform matters for patient engagement and treatment adherence, particularly for weight management programs that require long-term commitment.

Patient education content on Hers covers women-specific weight management topics - including the interaction between hormonal changes, menopause, and GLP-1 therapy - that Felix's more general content library does not address in the same depth. For women in perimenopause or dealing with hormonal weight changes, this contextually relevant content may improve program engagement.

Pros and Cons

Verdict

The right choice between Felix Health and Hers Canada depends on what you are optimizing for in a telehealth provider.

If your primary and sole goal is GLP-1 weight management, and you want transparent pricing, a specialist clinical protocol, and a well-tested Canadian platform - Felix Health wins. Its bundled pricing, GLP-1 specialization, and Canadian foundation make it the most complete option for that specific goal.

If you are a Canadian woman who wants a platform that treats your weight management in the broader context of your overall health - including mental health, hormonal health, and reproductive considerations - and you appreciate a platform designed specifically around women's experiences and communication preferences, Hers Canada has genuine advantages. The women-centric clinical framing and multi-category platform are meaningful for women navigating weight management alongside other health needs.

A practical middle path worth considering: use Felix for GLP-1 prescribing (specialist depth, transparent pricing, bundled support), and evaluate Hers for any other women's health needs where its platform excels. Neither platform mandates exclusivity, and the clinical needs they serve are largely complementary rather than competing.